Belgium· BE-AMP-SAM566026-00

Vaxelis

A diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b product containing hepatitis b virus surface antigen (recombinant), registered in Belgium by MCM Vaccine. The same ATC class is registered in 10 of our 19 countries.

ATC J07CA09

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVaxelisATCJ07CA09REGISTER NO.BE-AMP-SAM566026-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b is registered in 10 of 19 countries.

Countries holding a registration under ATC J07CA09 (diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b · ATC J07CA09

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Hepatitis B virus surface antigen (recombinant)
Manufacturer
MCM Vaccine
Country
Belgium (BE)
ATC code
J07CA09
ATC class
Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/41af9df4-53f8-4419-99c5-5d2141a7653f
GET /v1/drugs/41af9df4-53f8-4419-99c5-5d2141a7653f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Vaxelis",
  "name_fr": "Vaxelis",
  "name_nl": "Vaxelis",
  "amp_code": "SAM566026-00",
  "strengths": null,
  "pack_count": 1,
  "substances": [
    "Hepatitis B virus surface antigen (recombinant)",
    "Poliomyelitis Virus, Inactivated",
    "Haemophilus Influenzae Type b Polysaccharides, conjugated to Meningococcal Proteins",
    "Bordetella Pertussis Antigen, Adsorbed",
    "Tetanus Toxoid Adsorbed",
    "Diphteria Antigen, Adsorbed",
    "Sodium Phosphate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Diphtheria-Haemophilus Influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B",
  "authorisation_numbers": [
    "EU/1/15/1079/008"
  ]
}

See everything about diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.